大腸がん診断市場：2030年までの動向、予測、競合分析

大腸がん診断の動向と予測

世界の大腸がん診断市場は、2030年までに推定338億米ドルに達すると予測されており、2024年から2030年までのCAGRは6.5%で成長すると予測されています。この市場の主な促進要因は、がん疾患の有病率の増加、意識の高まりと早期診断法、ヘルスケア支出の増加です。世界の大腸がん診断市場の将来は、病院、診断センター、がん研究センター、外来手術センター市場における機会で有望視されています。

大腸がん診断のセグメント別推移

本調査では、大腸がん診断の製品タイプ別、がんタイプ別、年齢層別、エンドユース別、地域別の世界予測を掲載しています。

大腸がん診断市場洞察

• Lucintel社の予測では、がん診断のためのヘルスケア支出の増加や予防医療への嗜好の高まりにより、医療機器が予測期間中に最も高い成長を遂げる見込みです。
• この市場の中では、大腸がん疾患に対する費用対効果の高い診断施設に対するニーズの高まりと世界の診断センター数の増加により、診断センターが引き続き最大セグメントとなります。
• 北米は、先進的な診断手順や診断技術が利用可能であり、大腸がん診断検査に対する需要が高まっていることから、予測期間中に最も高い成長が見込まれます。

よくある質問

Q.1大腸がん診断市場規模は？

A1.世界の大腸がん診断市場は2030年までに338億米ドルに達すると推定されています。

Q.2大腸がん診断市場の成長予測は？

A2.世界の大腸がん診断市場は、2024年から2030年にかけてCAGR6.5%で成長すると予測されます。

Q.3大腸がん診断市場の成長に影響を与える主な促進要因は何ですか？

A3.この市場の主な促進要因は、がん疾患の有病率の増加、認知度の向上、早期診断法、ヘルスケア支出の増加です。

Q4.市場の主要セグメントは：

A4.大腸がん診断市場の将来は、病院、診断センター、がん研究センター、外来手術センターの各市場における機会により有望と思われます。

Q5.市場の主要企業は：

A5.大腸がん診断の主要企業は以下の通り：

• General Electric
• Siemens Healthcare
• Koninklijke Philips
• F. Hoffmann-La Roche
• Abbott
• Illumina
• Qiagen
• Thermo Fisher Scientific
• Quest Diagnostics
• Merck

Q6.今後、最大となる市場セグメントは：

A6.Lucintelは、がん診断のためのヘルスケア支出の増加と予防医療への嗜好の高まりから、予測期間中、医療機器が最も高い成長を遂げると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は：

A7.北米は、高度な診断手順や技術が利用可能であり、大腸がん診断検査に対する需要が高まっているため、予測期間中に最も高い成長が見込まれます。

Q8.レポートのカスタマイズは可能か：

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の大腸がん診断市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の大腸がん診断市場の動向（2018～2023年）と予測（2024～2030年）
• 製品タイプ別世界の大腸がん診断市場
  • 機器
  • 消耗品とアクセサリー
• がん種別大腸がん診断市場の世界規模
  • 腺がん
  • 大腸リンパ腫
  • 消化管間質腫瘍
  • カルチノイド腫瘍
  • その他
• 年齢グループ別世界の大腸がん診断市場
  • 老年
  • 成人
  • 小児
• 最終用途別世界の大腸がん診断市場
  • 病院
  • 診断センター
  • がん研究センター
  • 外来手術センター
  • その他

第4章 2018年から2030年までの地域別市場動向と予測分析

• 地域別大腸がん診断市場
• 北米の大腸がん診断市場
• 欧州の大腸がん診断市場
• アジア太平洋地域の大腸がん診断市場
• その他地域の大腸がん診断市場

第5章 競合分析

• 製品ポートフォリオ分析
• 業務統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 製品タイプ別の世界の大腸がん診断市場の成長機会
  • がんの種類別世界の大腸がん診断市場の成長機会
  • 年齢層別世界の大腸がん診断市場の成長機会
  • 最終用途別の世界の大腸がん診断市場の成長機会
  • 地域別の世界の大腸がん診断市場の成長機会
• 世界の大腸がん診断市場の新たな動向
• 戦略分析
  • 新製品の開発
  • 世界の大腸がん診断市場の能力拡大
  • 世界の大腸がん診断市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• General Electric
• Siemens Healthcare
• Koninklijke Philips
• F. Hoffmann-La Roche
• Abbott
• Illumina
• QIAGEN
• Thermo Fisher Scientific
• Quest Diagnostics
• Merck .

Colorectal Cancer Diagnostic Trends and Forecast

The future of the global colorectal cancer diagnostic market looks promising with opportunities in the hospital, diagnostic center, cancer research center, and ambulatory surgical center markets.The global colorectal cancer diagnostic market is expected to reach an estimated $33.8 billion by 2030, and it is forecast to grow at a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing prevalence of cancer diseases, rising awareness and early diagnostic procedures, and increasing healthcare expenditure.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Colorectal Cancer Diagnostic by Segment

The study includes a forecast for the global colorectal cancer diagnostic by product type, cancer type, age group, end use, and region.

Colorectal Cancer Diagnostic Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Instruments
• Consumables & Accessories

Colorectal Cancer Diagnostic Market by Cancer Type [Shipment Analysis by Value from 2018 to 2030]:

• Adenocarcinoma
• Colorectal Lymphoma
• Gastrointestinal Stromal Tumors
• Carcinoid Tumors
• Others

Colorectal Cancer Diagnostic Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

• Geriatric
• Adults
• Pediatric

Colorectal Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostic Centers
• Cancer Research Centers
• Ambulatory Surgical Centers
• Others

Colorectal Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Colorectal Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies colorectal cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the colorectal cancer diagnostic companies profiled in this report include-

• General Electric
• Siemens Healthcare
• Koninklijke Philips
• F. Hoffmann-La Roche
• Abbott
• Illumina
• Qiagen
• Thermo Fisher Scientific
• Quest Diagnostics
• Merck

Colorectal Cancer Diagnostic Market Insights

• Lucintel forecasts that instruments is expected to witness highest growth over the forecast period due to the growing healthcare expenditure for cancer diagnosis and increasing preference for preventive healthcare measures.
• Within this market, diagnostic centers will remain the largest segment due to growing need for cost effective diagnosis facilities for colorectal cancer disease and rising number of diagnostic centers globally.
• North America is expected to witness highest growth over the forecast period due to availability of advanced diagnostic procedure and techniques and growing demand for colorectal cancer diagnostics testing.

Features of the Global Colorectal Cancer Diagnostic Market

• Market Size Estimates: Colorectal cancer diagnostic market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
• Segmentation Analysis: Colorectal cancer diagnostic market size by various segments, such as by product type, cancer type, age group, end use, and region in terms of ($B).
• Regional Analysis: Colorectal cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different product types, cancer types, age groups, end uses, and regions for the colorectal cancer diagnostic market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the colorectal cancer diagnostic market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the colorectal cancer diagnostic market size?

Answer: The global colorectal cancer diagnostic market is expected to reach an estimated $33.8 billion by 2030.

Q.2 What is the growth forecast for colorectal cancer diagnostic market?

Answer: The global colorectal cancer diagnostic market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the colorectal cancer diagnostic market?

Answer: The major drivers for this market are increasing prevalence of cancer diseases, rising awareness and early diagnostic procedures and increasing healthcare expenditure.

Q4. What are the major segments for colorectal cancer diagnostic market?

Answer: The future of the colorectal cancer diagnostic market looks promising with opportunities in the hospital, diagnostic center, cancer research center, and ambulatory surgical center markets.

Q5. Who are the key colorectal cancer diagnostic market companies?

Answer: Some of the key colorectal cancer diagnostic companies are as follows:

• General Electric
• Siemens Healthcare
• Koninklijke Philips
• F. Hoffmann-La Roche
• Abbott
• Illumina
• Qiagen
• Thermo Fisher Scientific
• Quest Diagnostics
• Merck

Q6. Which colorectal cancer diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that instruments is expected to witness highest growth over the forecast period due to the growing healthcare expenditure for cancer diagnosis and increasing preference for preventive healthcare measures.

Q7. In colorectal cancer diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to availability of advanced diagnostic procedure and techniques and growing demand for colorectal cancer diagnostics testing.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the colorectal cancer diagnostic market by product type (instruments and consumables & accessories), cancer type (adenocarcinoma, colorectal lymphoma, gastrointestinal stromal tumors, carcinoid tumors, and others), age group (geriatric, adults, and pediatric), end use (hospitals, diagnostic centers, cancer research centers, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Colorectal Cancer Diagnostic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1: Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2: Global Colorectal Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Colorectal Cancer Diagnostic Market by Product Type
  • 3.3.1: Instruments
  • 3.3.2: Consumables & Accessories
• 3.4: Global Colorectal Cancer Diagnostic Market by Cancer Type
  • 3.4.1: Adenocarcinoma
  • 3.4.2: Colorectal Lymphoma
  • 3.4.3: Gastrointestinal Stromal Tumors
  • 3.4.4: Carcinoid Tumors
  • 3.4.5: Others
• 3.5: Global Colorectal Cancer Diagnostic Market by Age Group
  • 3.5.1: Geriatric
  • 3.5.2: Adults
  • 3.5.3: Pediatric
• 3.6: Global Colorectal Cancer Diagnostic Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Diagnostic Centers
  • 3.6.3: Cancer Research Centers
  • 3.6.4: Ambulatory Surgical Centers
  • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Colorectal Cancer Diagnostic Market by Region
• 4.2: North American Colorectal Cancer Diagnostic Market
  • 4.2.1: North American Colorectal Cancer Diagnostic Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, and Others
• 4.3: European Colorectal Cancer Diagnostic Market
  • 4.3.1: European Colorectal Cancer Diagnostic Market by Product Type: Instruments and Consumables & Accessories
  • 4.3.2: European Colorectal Cancer Diagnostic Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, and Others
• 4.4: APAC Colorectal Cancer Diagnostic Market
  • 4.4.1: APAC Colorectal Cancer Diagnostic Market by Product Type: Instruments and Consumables & Accessories
  • 4.4.2: APAC Colorectal Cancer Diagnostic Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, and Others
• 4.5: ROW Colorectal Cancer Diagnostic Market
  • 4.5.1: ROW Colorectal Cancer Diagnostic Market by Product Type: Instruments and Consumables & Accessories
  • 4.5.2: ROW Colorectal Cancer Diagnostic Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by Cancer Type
  • 6.1.3: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by Age Group
  • 6.1.4: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by End Use
  • 6.1.5: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by Region
• 6.2: Emerging Trends in the Global Colorectal Cancer Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Colorectal Cancer Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Colorectal Cancer Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: General Electric
• 7.2: Siemens Healthcare
• 7.3: Koninklijke Philips
• 7.4: F. Hoffmann-La Roche
• 7.5: Abbott
• 7.6: Illumina
• 7.7: QIAGEN
• 7.8: Thermo Fisher Scientific
• 7.9: Quest Diagnostics
• 7.10: Merck .